データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13
Vertex Gets Expanded FDA Approval for Cystic Fibrosis Treatment
Vertex Announces US FDA Approval of ALYFTREK, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis
Vertex Announces U.S. FDA Approval for TRIKAFTA (Elexacaftor/tezacaftor/ivacaftor and Ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants
Vertex(VERX.US)非成瘾性止痛药遭遇“安慰剂效应” 分析师称其带来挫折
Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy